Rate of Neonatal Abstinence Syndrome, Maternal Opioid-Related Diagnoses in US

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JANUARY 12, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24991?guestAccessKey=83bccccd-b9e4-4601-8a84-c5f590385836&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011221

 

What The Study Did: Variations and changes in national and state rates of neonatal abstinence syndrome and maternal opioid-related diagnoses were examined in this observational study.

Authors: Ashley H. Hirai, Ph.D., of the Health Resources and Services Administration in Rockville, Maryland, is the corresponding author.

 

(doi:10.1001/jama.2020.24991)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.